Nifty

:

22620.40

Sensex

:

74398.48

50.05 (0.22%)
59.04 (0.08%)

Login

Nifty
Sensex

:
:

22620.40
74398.48

50.05 (0.22%)
59.04 (0.08%)

Suven Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :

57/99

BSE: 543064 | NSE: SUVENPHAR

Watchlist

NSE BSE

646.80

25-Apr-2024

Open
High
Low
Previous Close

640.00
649.85
635.75
641.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

271782
1750.64
768.00
468.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

16,447.44
44.35
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

16,435.77
0.93%
8.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
28.82
9.90

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
27.32
5.31

PAT CAGR (%)

10 Years
5 Years
3 Years

-
30.36
10.05

P:E (Median)

8 Years
5 Years
3 Years

-
-
31.97

P:BV (Average)

8 Years
5 Years
3 Years

-
-
8.64

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
23.33

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 212.83 348.49 -38.93% 224.62 278.40 -19.32% 344.03 338.80 1.54% 364.39 363.85 0.15%
Expenses 144.69 201.42 -28.17% 127.27 171.76 -25.90% 174.14 184.06 -5.39% 189.76 206.28 -8.01%
EBITDA 68.14 147.07 -53.67% 97.35 106.64 -8.71% 169.88 154.74 9.78% 174.63 157.57 10.83%
EBIDTM 32.02% 42.20% 43.34% 38.31% 49.38% 45.67% 47.92% 43.31%
Other Income 13.97 12.51 11.67% 14.20 10.39 36.67% 10.06 10.90 -7.71% 10.75 134.40 -92.00%
Interest 1.27 1.38 -7.97% 0.50 0.29 72.41% 1.15 1.43 -19.58% 2.29 2.19 4.57%
Depreciation 11.33 10.91 3.85% 10.48 10.76 -2.60% 11.15 10.55 5.69% 10.63 10.42 2.02%
PBT 69.50 147.28 -52.81% 100.57 105.99 -5.11% 167.65 153.66 9.10% 172.46 279.35 -38.26%
Tax 17.14 37.82 -54.68% 25.84 27.06 -4.51% 43.35 39.61 9.44% 42.30 54.89 -22.94%
PAT 52.36 109.47 -52.17% 74.73 78.92 -5.31% 124.29 114.05 8.98% 130.16 224.46 -42.01%
PATM 24.60% 31.41% 33.27% 28.35% 36.13% 33.66% 35.72% 61.69%
EPS 2.06 4.30 -52.09% 2.94 3.10 -5.16% 4.88 4.48 8.93% 5.11 8.82 -42.06%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 219.82 353.77 -37.86% 231.05 278.40 -17.01% 347.55 338.80 2.58% 369.36 363.85 1.51%
Expenses 154.68 207.08 -25.30% 133.09 178.52 -25.45% 180.58 187.92 -3.91% 200.28 206.83 -3.17%
EBITDA 65.14 146.70 -55.60% 97.96 99.88 -1.92% 166.97 150.88 10.66% 169.08 157.02 7.68%
EBIDTM 29.64% 41.47% 42.40% 35.88% 48.04% 44.53% 45.78% 43.16%
Other Income 14.34 13.01 10.22% 19.84 10.92 81.68% 10.67 11.03 -3.26% 11.40 16.87 -32.42%
Interest 1.27 1.38 -7.97% 0.50 0.29 72.41% 1.15 1.45 -20.69% 2.31 2.19 5.48%
Depreciation 12.75 12.24 4.17% 11.89 12.03 -1.16% 12.54 11.50 9.04% 11.96 10.42 14.78%
PBT 65.47 146.08 -55.18% 105.41 98.48 7.04% 163.94 148.96 10.06% 166.21 161.28 3.06%
Tax 18.71 38.36 -51.23% 25.84 26.42 -2.20% 43.35 41.42 4.66% 42.24 69.61 -39.32%
PAT 46.75 107.72 -56.60% 79.56 72.06 10.41% 120.59 107.54 12.14% 123.97 91.67 35.24%
PATM 21.27% 30.45% 34.43% 25.88% 34.70% 31.74% 33.56% 25.19%
EPS 1.84 4.23 -56.50% 3.13 2.83 10.60% 4.74 4.22 12.32% 4.87 3.60 35.28%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 1,145.87 1,330.08 1,320.22 1,009.72 833.79 377.83 Net Sales Growth -13.81% 0.75% 30.75% 21.10% 120.68% Cost Of Goods Sold 332.53 394.26 394.05 297.56 225.32 101.46 Gross Profit 813.34 935.83 926.17 712.16 608.47 276.37 GP Margin 70.98% 70.36% 70.15% 70.53% 72.98% 73.15% Total Expenditure 635.86 739.65 737.94 566.68 449.00 206.28 Power & Fuel Cost - 71.35 59.55 44.20 38.23 18.06 % Of Sales - 5.36% 4.51% 4.38% 4.59% 4.78% Employee Cost - 100.84 100.48 76.23 65.10 29.63 % Of Sales - 7.58% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 114.57 129.24 105.31 83.89 35.11 % Of Sales - 8.61% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 31.30 28.43 27.69 25.93 12.62 % Of Sales - 2.35% 2.15% 2.74% 3.11% 3.34% Selling & Distn. Exp. - 17.43 19.80 10.53 9.43 6.72 % Of Sales - 1.31% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 9.90 6.37 5.16 1.08 2.69 % Of Sales - 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 510.00 590.43 582.28 443.04 384.79 171.55 EBITDA Margin 44.51% 44.39% 44.10% 43.88% 46.15% 45.40% Other Income 48.98 44.55 187.79 14.24 18.12 0.60 Interest 5.21 12.75 8.53 11.66 21.81 2.79 Depreciation 43.59 42.84 39.10 31.64 23.51 11.50 PBT 510.18 579.39 722.45 413.98 357.59 157.87 Tax 128.63 146.79 164.35 105.33 87.51 48.59 Tax Rate 25.21% 25.34% 22.75% 25.44% 24.47% 30.78% PAT 381.54 432.60 558.10 308.65 270.08 109.27 PAT before Minority Interest 381.54 432.60 558.10 308.65 270.08 109.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 33.30% 32.52% 42.27% 30.57% 32.39% 28.92% PAT Growth -27.59% -22.49% 80.82% 14.28% 147.17% EPS 14.99 16.99 21.92 12.12 10.61 4.29

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 1,167.78 1,340.33 1,320.22 1,009.72 833.79 377.83 Net Sales Growth -12.51% 1.52% 30.75% 21.10% 120.68% Cost Of Goods Sold 347.75 402.97 394.05 297.56 225.32 101.46 Gross Profit 820.03 937.36 926.17 712.16 608.47 276.37 GP Margin 70.22% 69.94% 70.15% 70.53% 72.98% 73.15% Total Expenditure 668.63 766.42 738.50 566.72 449.03 206.28 Power & Fuel Cost - 73.93 59.55 44.20 38.23 18.06 % Of Sales - 5.52% 4.51% 4.38% 4.59% 4.78% Employee Cost - 110.51 100.48 76.23 65.10 29.63 % Of Sales - 8.24% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 117.43 129.24 105.31 83.89 35.11 % Of Sales - 8.76% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 34.05 28.99 27.73 25.97 12.62 % Of Sales - 2.54% 2.20% 2.75% 3.11% 3.34% Selling & Distn. Exp. - 17.64 19.80 10.53 9.43 6.72 % Of Sales - 1.32% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 9.90 6.37 5.16 1.08 2.69 % Of Sales - 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 499.15 573.91 581.72 443.00 384.76 171.55 EBITDA Margin 42.74% 42.82% 44.06% 43.87% 46.15% 45.40% Other Income 56.25 46.36 92.38 14.24 18.12 0.60 Interest 5.23 12.81 8.53 11.67 23.07 2.79 Depreciation 49.14 47.73 39.10 31.64 23.51 11.50 PBT 501.03 559.73 626.48 413.94 356.30 157.87 Tax 130.14 148.44 213.78 105.33 87.51 48.59 Tax Rate 25.97% 26.52% 34.12% 25.45% 24.56% 30.78% PAT 370.87 411.29 453.80 308.61 268.79 109.27 PAT before Minority Interest 370.87 411.29 453.80 308.61 268.79 109.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 31.76% 30.69% 34.37% 30.56% 32.24% 28.92% PAT Growth -2.14% -9.37% 47.05% 14.81% 145.99% EPS 14.57 16.15 17.82 12.12 10.56 4.29

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 1,749.38 1,520.69 1,065.18 782.83 590.29 Share Capital 25.46 25.46 25.46 12.73 0.00 Total Reserves 1,723.92 1,495.24 1,039.73 770.10 577.56 Non-Current Liabilities 54.77 75.19 73.91 127.68 35.12 Secured Loans 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 7.87 8.89 6.65 8.31 5.95 Current Liabilities 298.50 346.23 321.49 319.85 190.67 Trade Payables 61.96 105.90 82.93 71.06 53.57 Other Current Liabilities 23.45 28.25 28.56 27.51 19.47 Short Term Borrowings 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 148.48 144.94 104.36 127.24 34.83 Total Liabilities 2,102.65 1,942.11 1,460.58 1,230.36 816.08 Net Block 512.03 534.19 441.16 356.74 270.90 Gross Block 714.20 693.81 569.62 456.66 347.41 Accumulated Depreciation 202.17 159.62 128.46 99.91 76.51 Non Current Assets 1,003.21 695.93 794.13 719.36 393.28 Capital Work in Progress 164.81 29.99 96.32 101.71 111.07 Non Current Investment 317.21 118.67 245.65 245.65 0.07 Long Term Loans & Adv. 9.16 13.07 10.85 15.06 11.02 Other Non Current Assets 0.00 0.00 0.16 0.20 0.22 Current Assets 1,099.44 1,246.19 666.45 511.00 422.80 Current Investments 392.85 481.22 180.59 30.67 7.06 Inventories 311.47 283.42 201.08 174.87 157.10 Sundry Debtors 109.66 236.37 102.38 117.20 147.50 Cash & Bank 46.23 32.95 9.56 13.96 12.90 Other Current Assets 239.23 9.15 56.03 39.74 98.24 Short Term Loans & Adv. 228.50 203.08 116.80 134.56 37.32 Net Current Assets 800.94 899.96 344.96 191.15 232.13 Total Assets 2,102.65 1,942.12 1,460.58 1,230.36 816.08

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 1,735.18 1,527.18 1,180.81 844.76 590.29 Share Capital 25.46 25.46 25.46 12.73 0.00 Total Reserves 1,709.73 1,501.72 1,155.35 832.03 577.56 Non-Current Liabilities 71.79 92.11 73.91 127.68 35.12 Secured Loans 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 8.30 8.89 6.65 8.31 5.95 Current Liabilities 303.09 347.52 321.51 319.85 190.67 Trade Payables 65.16 105.90 82.93 71.06 53.57 Other Current Liabilities 24.76 29.54 28.57 27.51 19.47 Short Term Borrowings 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 148.56 144.94 104.36 127.24 34.83 Total Liabilities 2,110.06 1,966.81 1,576.23 1,292.29 816.08 Net Block 663.33 534.19 441.16 356.74 270.90 Gross Block 877.12 693.81 569.62 456.66 347.41 Accumulated Depreciation 213.80 159.62 128.46 99.91 76.51 Non Current Assets 954.70 701.66 909.68 781.17 393.28 Capital Work in Progress 165.09 29.99 96.32 101.71 111.07 Non Current Investment 117.10 117.10 361.19 307.46 0.07 Long Term Loans & Adv. 9.19 13.07 10.85 15.06 11.02 Other Non Current Assets 0.00 7.30 0.16 0.20 0.22 Current Assets 1,155.37 1,265.16 666.54 511.12 422.80 Current Investments 418.94 481.22 180.59 30.67 7.06 Inventories 312.81 283.42 201.08 174.87 157.10 Sundry Debtors 110.94 236.37 102.38 117.20 147.50 Cash & Bank 68.01 47.31 9.65 14.07 12.90 Other Current Assets 244.67 9.15 56.03 39.74 98.24 Short Term Loans & Adv. 233.21 207.69 116.80 134.56 37.32 Net Current Assets 852.28 917.64 345.04 191.27 232.13 Total Assets 2,110.07 1,966.82 1,576.22 1,292.29 816.08

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 484.17 269.89 328.84 358.75 50.40 PBT 579.39 722.45 413.98 357.59 157.87 Adjustment 28.33 -110.18 36.48 33.35 13.93 Changes in Working Capital 22.24 -190.63 -12.19 54.22 -88.33 Cash after chg. in Working capital 629.96 421.64 438.27 445.16 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -145.79 -151.74 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -235.57 -90.30 -257.66 -366.65 -65.48 Net Fixed Assets -155.21 -57.86 -107.57 -99.89 Net Investments -110.17 -173.65 -149.92 -269.19 Others 29.81 141.21 -0.17 2.43 Cash from Financing Activity -235.79 -156.48 -75.66 8.58 25.98 Net Cash Inflow / Outflow 12.81 23.12 -4.49 0.67 10.90 Opening Cash & Equivalents 30.21 7.09 11.58 10.90 0.00 Closing Cash & Equivalent 43.02 30.21 7.09 11.58 10.90

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 450.91 330.00 382.55 406.92 50.40 PBT 559.73 667.59 467.67 404.51 157.87 Adjustment 31.34 40.63 36.48 34.60 13.93 Changes in Working Capital 5.64 -193.97 -12.17 54.21 -88.33 Cash after chg. in Working capital 596.70 514.26 491.98 493.33 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -145.79 -184.26 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -194.84 -136.14 -311.40 -413.45 -65.48 Net Fixed Assets -155.21 -57.86 -107.57 -99.89 Net Investments -110.17 -173.65 -149.92 -269.19 Others 70.54 95.37 -53.91 -44.37 Cash from Financing Activity -235.83 -156.48 -75.66 7.32 25.98 Net Cash Inflow / Outflow 20.24 37.38 -4.51 0.79 10.90 Opening Cash & Equivalents 44.56 7.18 11.70 10.90 0.00 Closing Cash & Equivalent 64.80 44.56 7.18 11.70 10.90

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 68.72 59.74 41.84 30.75 0.00 ROA 21.39% 32.80% 22.94% 26.40% 13.39% ROE 26.46% 43.17% 33.40% 39.71% 18.92% ROCE 34.48% 51.79% 39.15% 46.23% 23.87% Fixed Asset Turnover 1.89 2.09 1.97 2.07 1.09 Receivable days 47.44 46.80 39.69 57.94 142.49 Inventory Days 81.55 66.93 67.95 72.66 151.76 Payable days 77.70 87.45 94.44 49.88 86.75 Cash Conversion Cycle 51.29 26.27 13.19 80.72 207.50 Total Debt/Equity 0.04 0.06 0.13 0.24 0.14 Interest Cover 46.45 85.72 36.49 17.39 57.60

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 68.16 59.99 46.39 33.18 0.00 ROA 20.18% 25.62% 21.52% 25.50% 13.39% ROE 25.21% 33.52% 30.47% 37.80% 18.92% ROCE 33.41% 45.92% 36.19% 44.55% 23.87% Fixed Asset Turnover 1.71 2.09 1.97 2.07 1.09 Receivable days 47.25 46.80 39.69 57.94 142.49 Inventory Days 81.11 66.93 67.95 72.66 151.76 Payable days 77.47 87.45 94.44 49.88 86.75 Cash Conversion Cycle 50.89 26.27 13.19 80.72 207.50 Total Debt/Equity 0.04 0.06 0.12 0.22 0.14 Interest Cover 44.69 79.29 36.48 16.45 57.60

Top Investors:

jasti property and equity holdings private limited (initscapacityassoletrusteeofjastifamilytrust)

dsp equity savings fund

uti-unit linked insurance plan

hsbc midcap fund

goldman sachs funds - goldman sachs india equity p

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA completes inspections at Suven Pharmaceuticals’ API, Formulations facilities
23rd Feb 2024, 17:15 PM

The inspections were conducted from February 12, 2024, to February 23, 2024
Read More
Suven Pharma - Quarterly Results
5th Feb 2024, 17:19 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback